Cargando…
Propranolol or atenolol for the management of infantile hemangioma: Implications for long-term health
Autores principales: | Hermans, Mireille M., Pasmans, Suzanne G.M.A., de Laat, Peter C.J., Slieker, Martijn G., Mendels, Elodie J., de Graaf, Marlies, Langeveld, Hester R., Schappin, Renske, Rietman, André B., Breugem, Corstiaan C., Breur, Johannes M.P.J., de Wildt, Saskia N., Raphael, Martine F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10148149/ https://www.ncbi.nlm.nih.gov/pubmed/37128266 http://dx.doi.org/10.1016/j.jdin.2023.02.001 |
Ejemplares similares
-
Long-term neurocognitive functioning of children treated with propranolol or atenolol for infantile hemangioma
por: Hermans, Mireille M., et al.
Publicado: (2022) -
Correction to: Long-term neurocognitive functioning of children treated with propranolol or atenolol for infantile hemangioma
por: Hermans, Mireille M., et al.
Publicado: (2023) -
Aesthetic Outcome of Propranolol vs Atenolol Treatment of Children with Infantile Haemangioma
por: HERMANS, Mireille M., et al.
Publicado: (2022) -
Prognostic Factors for Long-term Aesthetic Outcome of Infantile Haemangioma Treated with Beta-blockers
por: HERMANS, Mireille M., et al.
Publicado: (2023) -
A survey on the application of oral propranolol and atenolol for the management of infantile hemangiomas in mainland China: Survey on propranolol atenolol hemangiomas
por: Zhao, Ze-Liang, et al.
Publicado: (2021)